Detailed Information

Cited 13 time in webofscience Cited 11 time in scopus
Metadata Downloads

A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder

Authors
Park, Seon-CheolKim, Yong-Ku
Issue Date
Jan-2019
Publisher
KOREAN NEUROPSYCHIATRIC ASSOC
Keywords
Bio-psychosocial-behavioral; Cognitive-behavioral therapy; Fear circuit; Research Domain Criteria; Panic disorder
Citation
PSYCHIATRY INVESTIGATION, v.16, no.1, pp 4 - 15
Pages
12
Indexed
SCIE
SSCI
SCOPUS
KCI
Journal Title
PSYCHIATRY INVESTIGATION
Volume
16
Number
1
Start Page
4
End Page
15
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/2544
DOI
10.30773/pi.2018.08.21.1
ISSN
1738-3684
1976-3026
Abstract
To conceptualize a novel bio-psychosocial-behavioral treatment model of panic disorder (PD), it is necessary to completely integrate behavioral, psychophysiological, neurobiological, and genetic data. Molecular genetic research on PD is specifically focused on neurotransmitters, including serotonin, neuropeptides, glucocorticoids, and neurotrophins. Although pharmacological interventions for PD are currently available, the need for more effective, faster-acting, and more tolerable pharmacological interventions is unmet. Thus, glutamatergic receptor modulators, orexin receptor antagonists, corticotrophin-releasing factor 1 receptor antagonists, and other novel mechanism-based anti-panic therapeutics have been proposed. Research on the neural correlates of PD is focused on the dysfunctional "cross-talk" between emotional drive (limbic structure) and cognitive inhibition (prefrontal cortex) and the fear circuit, which includes the amygdala-hippocampus-prefrontal axis. The neural perspective regarding PD supports the idea that cognitive-behavioral therapy normalizes alterations in top-down cognitive processing, including increased threat expectancy and attention to threat. Consistent with the concept of "personalized medicine," it is speculated that Research Domain Criteria can enlighten further treatments targeting dysfunctions underlying PD more precisely and provide us with better definitions of moderators used to identify subgroups according to different responses to treatment. Structuring of the "negative valence systems" domain, which includes fear/anxiety, is required to define PD. Therefore, targeting glutamate-and orexin-related molecular mechanisms associated with the fear circuit, which includes the amygdala-hippocampus-prefrontal cortex axis, is required to define a novel bio-psychosocial-behavioral treatment model of PD.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Psychiatry > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Yong Ku photo

Kim, Yong Ku
Ansan Hospital (Department of Psychiatry, Ansan Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE